Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.47 |
| ▸ | FDPS | P14324 | 5/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL239718 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| SCHEMBL238536 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| SCHEMBL28188933 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| SCHEMBL10944415 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| SCHEMBL17201413 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| SCHEMBL10944412 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| SCHEMBL28359730 | 1.00 | SPHK1 (0.47) | SPHK1FDPSOPRM1LAP3LMNA | |
| Water SCHEMBL16398741 | 0.98 | SPHK1 (0.45) | SPHK1FDPSOPRM1LAP3LMNA | |
| Hydrochloric Acid SCHEMBL15917465 | 0.98 | SPHK1 (0.45) | SPHK1FDPSOPRM1LAP3LMNA | |
| Hydrochloric Acid SCHEMBL28887929 | 0.98 | SPHK1 (0.45) | SPHK1FDPSOPRM1LAP3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1686962-B9 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2012-10-03 | — | — | EP | claimed |
| EP-1871345-B1 | NANOPARTICULATE ERLOTINIB FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2012-08-01 | — | — | EP | claimed |
| EP-1585502-B9 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2012-05-09 | — | — | EP | claimed |
| EP-1553927-B9 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2011-09-21 | — | — | EP | claimed |
| EP-1585502-B1 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2011-06-29 | — | — | EP | claimed |
| EP-1686962-B1 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2011-05-18 | — | — | EP | claimed |
| EP-1553927-B1 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2010-11-10 | — | — | EP | claimed |
| EP-1490030-B2 | NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | ELAN PHARMA INT LTD (IE) | 2010-07-14 | — | — | EP | claimed |
| EP-1617816-B1 | NANOPARTICULATE MELOXICAN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2009-05-13 | — | — | EP | claimed |
| EP-1651189-B1 | NOVEL METAXALONE COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2008-12-03 | — | — | EP | claimed |
| EP-1658053-B1 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | EP | claimed |
| EP-1490025-B1 | NANOPARTICULATE COMPOSITIONS OF MAP KINASE INHIBITORS | ELAN PHARMA INT LTD (IE) | 2008-02-13 | — | — | EP | claimed |
| EP-1443912-B1 | COMPOSITIONS HAVING A COMBINATION OF IMMEDIATE RELEASE AND CONTROLLED RELEASE CHARACTERISTICS | ELAN PHARMA INT LTD (IE) | 2007-08-29 | — | — | EP | claimed |
| EP-1429731-B1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2007-01-03 | — | — | EP | claimed |
| EP-1490030-B1 | NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | ELAN PHARMA INT LTD (IE) | 2006-10-25 | — | — | EP | claimed |
| WO-2023181826-A1 | SPECTACLE LENS AND METHOD FOR MANUFACTURING SAME | ホヤ レンズ タイランド リミテッド | 2023-09-28 | — | — | WO | disclosed |
| WO-2011077062-A1 | FLAVOURING FORMULATIONS IN THE FORM OF A NANODISPERSION | CAPSUM (FR) | 2011-06-30 | — | — | WO | disclosed |